Sponsored
  • Pharmaceutical Logistics Market
    #health #ict #technology

    Pharmaceutical Logistics Market reached USD 69.3 billion in 2021 and is estimated to touch USD 111.3 billion in 2029, Growing at a CAGR of 6.1% from 2022-2029
    The factors driving the growth of Pharmaceutical Logistics Market includes increase in the production of vaccines and medicines, rise in the sales of generic drugs

    For more info:
    https://gmiresearch.bcz.com/2023/01/09/pharmaceutical-logistics-market-size-share-analysis-forecast-2029/
    Pharmaceutical Logistics Market #health #ict #technology Pharmaceutical Logistics Market reached USD 69.3 billion in 2021 and is estimated to touch USD 111.3 billion in 2029, Growing at a CAGR of 6.1% from 2022-2029 The factors driving the growth of Pharmaceutical Logistics Market includes increase in the production of vaccines and medicines, rise in the sales of generic drugs For more info: https://gmiresearch.bcz.com/2023/01/09/pharmaceutical-logistics-market-size-share-analysis-forecast-2029/
    0 Comments 0 Shares 126 Views
  • Get Covid 19 vaccination in Paris Ontario by visiting the Community hub pharmacy. We are an independent pharmacy where you can get #corona #vaccines. We also provide a home vaccination facility so that those people who feel more comfortable at home can get their vaccine at their home. Learn more https://communityhubpharmacy.com/vaccine-next-dose-calculator
    Get Covid 19 vaccination in Paris Ontario by visiting the Community hub pharmacy. We are an independent pharmacy where you can get #corona #vaccines. We also provide a home vaccination facility so that those people who feel more comfortable at home can get their vaccine at their home. Learn more https://communityhubpharmacy.com/vaccine-next-dose-calculator
    0 Comments 0 Shares 192 Views
  • Get Covid 19 vaccination in Paris Ontario by visiting the Community hub pharmacy. We are an independent pharmacy where you can get #corona #vaccines. We also provide a home vaccination facility so that those people who feel more comfortable at home can get their vaccine at their home. Learn more https://communityhubpharmacy.com/vaccine-next-dose-calculator
    Get Covid 19 vaccination in Paris Ontario by visiting the Community hub pharmacy. We are an independent pharmacy where you can get #corona #vaccines. We also provide a home vaccination facility so that those people who feel more comfortable at home can get their vaccine at their home. Learn more https://communityhubpharmacy.com/vaccine-next-dose-calculator
    0 Comments 0 Shares 180 Views
  • Clinical Trial Management System Market
    #health

    The Clinical Trial Management System Market is estimated to expand at a robust CAGR over the forecast period
    The factors driving the growth of Clinical Trial Management System Market includes increase in the number of clinical studies around the world, growing focus on developing effective vaccines and rising prevalence of chronic and infectious diseases.

    For more info:
    https://gmireesearch.blogspot.com/2022/11/clinical-trial-management-system-market.html
    Clinical Trial Management System Market #health The Clinical Trial Management System Market is estimated to expand at a robust CAGR over the forecast period The factors driving the growth of Clinical Trial Management System Market includes increase in the number of clinical studies around the world, growing focus on developing effective vaccines and rising prevalence of chronic and infectious diseases. For more info: https://gmireesearch.blogspot.com/2022/11/clinical-trial-management-system-market.html
    0 Comments 0 Shares 68 Views
  • Anti-Venom Market
    Anti-venom is a medicine used for the treatment of bite from poisonous animals such as snake, scorpion, spider, jellyfish, stone fish and others. Monovalent and polyvalent are two sub categories of anti-venom. According to World Health Organization (WHO), monovalent anti-venoms are also known as monospecific anti-venom. Monospecific anti-venoms are limited in use to a single species of venomous snake or to a few closely related species, whose venoms show clinically effective cross-neutralization with anti-venom. Polyvalent are anti-venoms which are obtained by fractionating the plasma from animals which are immunized by a mixture of venoms from several species of venomous snakes. The Global Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.

    “Global Anti-Venom Market, By Type (Monovalent and Polyvalent), By Animal Type (Snake, Scorpion, Spider and Others), By Distribution Channel (Hospital, Retail Pharmacies and Others), and Region - Global Forecast to 2030"
    Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.Global anti-venom market is driven owing to it is unique treatment option available for insect bites specifically for snake. Further, growing incidences of scorpion bites, snake bites, and other animal or insect bites such as fish stings also drives growth of the global anti-venom market.
    Key Highlights:
    • In 2018, Pfizer, Inc. worked with the U.S. Food and Drug Administration (FDA), to extend the expiration date of Antivenin’s Lot No. L67530 for an additional 12 months.
    Before purchasing this report, request a sample or make an inquiry by clicking the following link:
    https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

    Key Market Insights from the report:
    The Global Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.The market report has been segmented on the basis of type, animal type, distribution channel, and region.
    • By type, the global anti-venom market is segmented into monovalent and polyvalent.
    • By animal type, the global anti-venom market is segmented into snake, scorpion, spider and others.
    • By distribution channel, the global anti-venom market is segmented into hospital, retail pharmacies and others.
    • By region, the North America region accounted major share in the global anti-venom market and is expected to retain its dominance over forecast period. This is attributed to the increasing incidences of scorpion bites and snake bites and rising expenditure on healthcare in North America region.

    The prominent player operating in the global anti-venom market include Boston Scientific Corporation, CSL Limited, Pfizer, Inc., Merck & Co., Inc., Bharat Serums and Vaccines Limited, Haffkine Bio-Pharmaceutical Corporation Ltd., Vins Bioproducts Limited, Incepta Pharmaceuticals Ltd., Medline Industries Inc. and Rare Disease Therapeutics Inc.

    Anti-Venom Market Anti-venom is a medicine used for the treatment of bite from poisonous animals such as snake, scorpion, spider, jellyfish, stone fish and others. Monovalent and polyvalent are two sub categories of anti-venom. According to World Health Organization (WHO), monovalent anti-venoms are also known as monospecific anti-venom. Monospecific anti-venoms are limited in use to a single species of venomous snake or to a few closely related species, whose venoms show clinically effective cross-neutralization with anti-venom. Polyvalent are anti-venoms which are obtained by fractionating the plasma from animals which are immunized by a mixture of venoms from several species of venomous snakes. The Global Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%. “Global Anti-Venom Market, By Type (Monovalent and Polyvalent), By Animal Type (Snake, Scorpion, Spider and Others), By Distribution Channel (Hospital, Retail Pharmacies and Others), and Region - Global Forecast to 2030" Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.Global anti-venom market is driven owing to it is unique treatment option available for insect bites specifically for snake. Further, growing incidences of scorpion bites, snake bites, and other animal or insect bites such as fish stings also drives growth of the global anti-venom market. Key Highlights: • In 2018, Pfizer, Inc. worked with the U.S. Food and Drug Administration (FDA), to extend the expiration date of Antivenin’s Lot No. L67530 for an additional 12 months. Before purchasing this report, request a sample or make an inquiry by clicking the following link: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230 Key Market Insights from the report: The Global Anti-Venom Market accounted for US$ 2.60 billion in 2020 and is estimated to be US$ 4.70 billion by 2030 and is anticipated to register a CAGR of 6.1%.The market report has been segmented on the basis of type, animal type, distribution channel, and region. • By type, the global anti-venom market is segmented into monovalent and polyvalent. • By animal type, the global anti-venom market is segmented into snake, scorpion, spider and others. • By distribution channel, the global anti-venom market is segmented into hospital, retail pharmacies and others. • By region, the North America region accounted major share in the global anti-venom market and is expected to retain its dominance over forecast period. This is attributed to the increasing incidences of scorpion bites and snake bites and rising expenditure on healthcare in North America region. The prominent player operating in the global anti-venom market include Boston Scientific Corporation, CSL Limited, Pfizer, Inc., Merck & Co., Inc., Bharat Serums and Vaccines Limited, Haffkine Bio-Pharmaceutical Corporation Ltd., Vins Bioproducts Limited, Incepta Pharmaceuticals Ltd., Medline Industries Inc. and Rare Disease Therapeutics Inc.
    Prophecy Market Insights | Research Reports & Business Consulting
    Prophecy Market Insights provides best Market Research Reports, competitive analysis & business consulting services to develop a go-to-market strategy.
    0 Comments 0 Shares 224 Views
  • 𝗪𝗵𝗮𝘁 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗥𝗲𝗾𝘂𝗶𝗿𝗲𝗱 𝗳𝗼𝗿 𝗖𝗼𝗹𝗼𝗿𝗮𝗱𝗼 𝗦𝗰𝗵𝗼𝗼𝗹𝘀
    𝗖𝗵𝗶𝗹𝗱 𝗖𝗮𝗿𝗲 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀
    Hepatitis B
    Diphtheria, tetanus, pertussis (DTap)
    Haemophilus influenza Type B (Hib)
    Inactivated poliovirus (IPV)
    Pneumococcal conjugate (PCV13)
    Measles, mumps, rubella (MMR)
    Varicella (chicken pox)

    𝗞𝗶𝗻𝗱𝗲𝗿𝗴𝗮𝗿𝘁𝗲𝗻 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝟭𝟮𝘁𝗵 𝗚𝗿𝗮𝗱𝗲
    𝗧𝗵𝗲 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗞-𝟭𝟮 𝘃𝗮𝗿𝘆 𝗯𝘆 𝗮𝗴𝗲.
    Hepatitis B
    Diphtheria, tetanus, pertussis (DTap)
    Inactivated poliovirus (IPV)
    Measles, mumps, rubella (MMR)
    Varicella (chicken pox)
    Tetanus, diphtheria, pertussis (Tdap)

    𝗪𝗵𝗮𝘁 𝗢𝘁𝗵𝗲𝗿 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗦𝗵𝗼𝘂𝗹𝗱 𝗜 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿 𝗳𝗼𝗿 𝗠𝘆 𝗖𝗵𝗶𝗹𝗱
    👉 COVID-19 Vaccine
    The COVID-19 vaccine is now available for all school-aged children.

    👉 Influenza Vaccine
    Influenza vaccines are recommended for everyone six months or older. The flu shot offers protection against illness for school children.

    👉 HPV Vaccine
    The HPV vaccine helps prevent human papillomavirus, which can lead to cervical and other types of cancer.

    𝗪𝗵𝗮𝘁 𝗜𝗳 𝗠𝘆 𝗖𝗵𝗶𝗹𝗱 𝗶𝘀 𝗔𝗳𝗿𝗮𝗶𝗱 𝗼𝗳 𝗦𝗵𝗼𝘁𝘀
    It’s normal for kids to be afraid of needles. We will do everything possible to ensure your child feels comfortable during their visit. Our healthcare team has training on how to calm fears and answer questions.

    𝗪𝗵𝗮𝘁 𝗔𝗿𝗲 𝗖𝗼𝗺𝗺𝗼𝗻 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁𝘀 𝗼𝗳 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀
    Most side effects from childhood vaccines are mild and go away within 24 hours. These symptoms usually last less than one day.


    🕿 (303) 688-8666
    🌐 https://www.foundersfamilymedicine.com/what-immunization-do-your-kids-need-for-back-to-school/
    𝗪𝗵𝗮𝘁 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗥𝗲𝗾𝘂𝗶𝗿𝗲𝗱 𝗳𝗼𝗿 𝗖𝗼𝗹𝗼𝗿𝗮𝗱𝗼 𝗦𝗰𝗵𝗼𝗼𝗹𝘀? 𝗖𝗵𝗶𝗹𝗱 𝗖𝗮𝗿𝗲 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀 ✅ Hepatitis B ✅ Diphtheria, tetanus, pertussis (DTap) ✅ Haemophilus influenza Type B (Hib) ✅ Inactivated poliovirus (IPV) ✅ Pneumococcal conjugate (PCV13) ✅ Measles, mumps, rubella (MMR) ✅ Varicella (chicken pox) 𝗞𝗶𝗻𝗱𝗲𝗿𝗴𝗮𝗿𝘁𝗲𝗻 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝟭𝟮𝘁𝗵 𝗚𝗿𝗮𝗱𝗲 𝗧𝗵𝗲 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗞-𝟭𝟮 𝘃𝗮𝗿𝘆 𝗯𝘆 𝗮𝗴𝗲. ✅ Hepatitis B ✅ Diphtheria, tetanus, pertussis (DTap) ✅ Inactivated poliovirus (IPV) ✅ Measles, mumps, rubella (MMR) ✅ Varicella (chicken pox) ✅ Tetanus, diphtheria, pertussis (Tdap) 𝗪𝗵𝗮𝘁 𝗢𝘁𝗵𝗲𝗿 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗦𝗵𝗼𝘂𝗹𝗱 𝗜 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿 𝗳𝗼𝗿 𝗠𝘆 𝗖𝗵𝗶𝗹𝗱? 👉 COVID-19 Vaccine The COVID-19 vaccine is now available for all school-aged children. 👉 Influenza Vaccine Influenza vaccines are recommended for everyone six months or older. The flu shot offers protection against illness for school children. 👉 HPV Vaccine The HPV vaccine helps prevent human papillomavirus, which can lead to cervical and other types of cancer. 𝗪𝗵𝗮𝘁 𝗜𝗳 𝗠𝘆 𝗖𝗵𝗶𝗹𝗱 𝗶𝘀 𝗔𝗳𝗿𝗮𝗶𝗱 𝗼𝗳 𝗦𝗵𝗼𝘁𝘀? It’s normal for kids to be afraid of needles. We will do everything possible to ensure your child feels comfortable during their visit. Our healthcare team has training on how to calm fears and answer questions. 𝗪𝗵𝗮𝘁 𝗔𝗿𝗲 𝗖𝗼𝗺𝗺𝗼𝗻 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁𝘀 𝗼𝗳 𝗩𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻𝘀? Most side effects from childhood vaccines are mild and go away within 24 hours. These symptoms usually last less than one day. 🕿 (303) 688-8666 🌐 https://www.foundersfamilymedicine.com/what-immunization-do-your-kids-need-for-back-to-school/
    0 Comments 0 Shares 243 Views
  • Prefilled Syringes Market
    #health
    The Prefilled Syringes Market is expected to reach USD 11,479 million by the end of 2027, expanding at a CAGR of 9% over the forecast period (2020-2027).
    The factors driving the growth of Prefilled Syringes Market includes growing demand for user-friendly drug delivery devices, rise in the cases of diabetes and increasing use of prefilled syringes in vaccines, therapeutic proteins, and blood stimulants.

    For more info:
    https://gmiresearch.bcz.com/2022/09/27/prefilled-syringes-market-size-share-report-2027/

    Prefilled Syringes Market #health The Prefilled Syringes Market is expected to reach USD 11,479 million by the end of 2027, expanding at a CAGR of 9% over the forecast period (2020-2027). The factors driving the growth of Prefilled Syringes Market includes growing demand for user-friendly drug delivery devices, rise in the cases of diabetes and increasing use of prefilled syringes in vaccines, therapeutic proteins, and blood stimulants. For more info: https://gmiresearch.bcz.com/2022/09/27/prefilled-syringes-market-size-share-report-2027/
    0 Comments 0 Shares 110 Views
  • Protein Engineering Market worth US$ 2.9 Billion 2024 with a CAGR of 15.80%

    The report "Global Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030.

    To know the upcoming trends and insights prevalent in this market, click the link below:

    Links:

    https://prophecymarketinsights.com/market_insight/Global-Protein-Engineering-Market-By-4118
    Protein Engineering Market worth US$ 2.9 Billion 2024 with a CAGR of 15.80% The report "Global Protein Engineering Market, By Product Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors, Vaccines, Growth Factors, and Other Product Types), By Technology (Irrational Protein Design, and Rational Protein Design), By End User (Pharmaceutical and Biotechnology Companies, Academic Institutions, and Contract Research Organizations), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030. To know the upcoming trends and insights prevalent in this market, click the link below: Links: https://prophecymarketinsights.com/market_insight/Global-Protein-Engineering-Market-By-4118
    PROPHECYMARKETINSIGHTS.COM
    Lung Cancer Diagnostic Test Market Size, Trends And Forecast To 2030
    The Biological Safety Cabinet Market is estimated to be US$ 7.22 Billion by 2030 with a CAGR of 11.5% during the forecast period
    0 Comments 0 Shares 167 Views
  • Influenza Vaccines Market is estimated to be US$ 9551.75 million by 2030 with a CAGR of 7.4% during the forecast period

    Influenza Vaccines, protect against the four influenza viruses that research indicates, an influenza A (H1N1) virus, an influenza A (H3N2) virus, and two influenza B viruses. Influenza is contagious respiratory infection, marked with fever, cough, joint pain, muscles, headache, and severe weakness. Further, according to the World Health Organization (WHO), 2018, influenza cases related hospitalization ranges in 3-5 million cases for severe illness.

    https://www.prophecymarketinsights.com/market_insight/Global-Influenza-Vaccines-Market-By-2513
    Influenza Vaccines Market is estimated to be US$ 9551.75 million by 2030 with a CAGR of 7.4% during the forecast period Influenza Vaccines, protect against the four influenza viruses that research indicates, an influenza A (H1N1) virus, an influenza A (H3N2) virus, and two influenza B viruses. Influenza is contagious respiratory infection, marked with fever, cough, joint pain, muscles, headache, and severe weakness. Further, according to the World Health Organization (WHO), 2018, influenza cases related hospitalization ranges in 3-5 million cases for severe illness. https://www.prophecymarketinsights.com/market_insight/Global-Influenza-Vaccines-Market-By-2513
    WWW.PROPHECYMARKETINSIGHTS.COM
    Influenza Vaccines Market Size - Trends, Analysis and Forecast till 2030
    Influenza Vaccines Market, By Type, By Application, By Region - Trends, Analysis and Forecast till 2029
    0 Comments 0 Shares 158 Views
  • Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50% during the forecast period
    Porcine Vaccine Market accounted for US$ 2.23 billion in 2020 and is estimated to be US$ 4.41 billion by 2030 and is anticipated to register a CAGR of 7.50%. The growth of huge, intensive pig operations has made effective vaccination imperative within the swine industry. This growth in size has been amid outbreaks of disease like porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea. These have caused massive losses, and effective vaccines aren't yet available. Older diseases like pleuropneumonia, erysipelas, enzootic pneumonia, proliferative enteritis, pseudorabies, and colibacillosis still persist, and classical swine fever and influenza remain as ongoing threats. The massive size of the many operations has required the introduction of mass vaccination procedures like vaccination through beverage. The present African swine fever pandemic makes the event of an efficient vaccine against this virus, a matter of urgent necessity.
    To know the upcoming trends and insights prevalent in this market, click the link below:

    https://www.prophecymarketinsights.com/market_insight/Global-Porcine-Vaccines-Market-By-2161
    Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50% during the forecast period Porcine Vaccine Market accounted for US$ 2.23 billion in 2020 and is estimated to be US$ 4.41 billion by 2030 and is anticipated to register a CAGR of 7.50%. The growth of huge, intensive pig operations has made effective vaccination imperative within the swine industry. This growth in size has been amid outbreaks of disease like porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea. These have caused massive losses, and effective vaccines aren't yet available. Older diseases like pleuropneumonia, erysipelas, enzootic pneumonia, proliferative enteritis, pseudorabies, and colibacillosis still persist, and classical swine fever and influenza remain as ongoing threats. The massive size of the many operations has required the introduction of mass vaccination procedures like vaccination through beverage. The present African swine fever pandemic makes the event of an efficient vaccine against this virus, a matter of urgent necessity. To know the upcoming trends and insights prevalent in this market, click the link below: https://www.prophecymarketinsights.com/market_insight/Global-Porcine-Vaccines-Market-By-2161
    WWW.PROPHECYMARKETINSIGHTS.COM
    Porcine Vaccine Market Size, Trends and Forecast To 2030
    The Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50% during the forecast period
    0 Comments 0 Shares 196 Views
More Results
Sponsored

Instant Money Transfers - Open Free Account

Mobile Money made easy, all currencies

Sponsored